1. by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's Lymphoma
by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu
Blood
Volume 90(8):
October 15, 1997
©1997 by American Society of Hematology

2. Survival of 82 patients with non-Hodgkin's lymphoma by the pretreatment S-VEGF level.
Survival of 82 patients with non-Hodgkin's lymphoma by the pretreatment S-VEGF level. The median (228 pg/mL) was used as the cut-off value. Survival rates at 24, 60, and 96 months are given.
Petri Salven et al. Blood 1997;90:
©1997 by American Society of Hematology